Cargando…

Animal Models of Multiple Sclerosis

To determine whether an immunological or pharmaceutical product has potential for therapy in treating multiple sclerosis (MS), detailed animal models are required. To date many animal models for human MS have been described in mice, rats, rabbits, guinea pigs, marmosets, and rhesus monkeys. The most...

Descripción completa

Detalles Bibliográficos
Autores principales:	Young, Colin R., Welsh, C. Jane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121393/ http://dx.doi.org/10.1007/978-1-59745-285-4_69

Ejemplares similares

Animal models of Multiple Sclerosis
por: Procaccini, Claudio, et al.
Publicado: (2015)

Animal models of multiple sclerosis—Potentials and limitations
por: Mix, Eilhard, et al.
Publicado: (2010)

Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis
por: Plastini, Melanie J., et al.
Publicado: (2020)

Effectiveness of exercise interventions in animal models of multiple sclerosis
por: Parnow, Abdolhossein, et al.
Publicado: (2023)

Animal models of multiple sclerosis: the good, the bad and the bottom line
por: Ransohoff, Richard M
Publicado: (2012)

Astrocytes Undergo Metabolic Reprogramming in the Multiple Sclerosis Animal Model
por: das Neves, Sofia Pereira, et al.
Publicado: (2023)

Gender effect on neurodegeneration and myelin markers in an animal model for multiple sclerosis
por: Massella, Alessandro, et al.
Publicado: (2012)

Pattern Recognition Receptors in Multiple Sclerosis and Its Animal Models
por: Deerhake, M. Elizabeth, et al.
Publicado: (2019)

Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis
por: Gharagozloo, Marjan, et al.
Publicado: (2022)

Contribution of Intravital Neuroimaging to Study Animal Models of Multiple Sclerosis
por: Buttigieg, Emeline, et al.
Publicado: (2023)

Remodeling of Axonal Connections Contributes to Recovery in an Animal Model of Multiple Sclerosis
por: Kerschensteiner, Martin, et al.
Publicado: (2004)

Vitamin D—An Effective Antioxidant in an Animal Model of Progressive Multiple Sclerosis
por: Haindl, Michaela Tanja, et al.
Publicado: (2023)

Theiler’s virus-induced demyelinating disease as an infectious model of progressive multiple sclerosis
por: Pike, Steven C., et al.
Publicado: (2022)

Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple Sclerosis
por: Yandamuri, Soumya S., et al.
Publicado: (2016)

The emerging roles of piezo1 channels in animal models of multiple sclerosis
por: Yang, Kai, et al.
Publicado: (2022)

The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use
por: Birmpili, Dafni, et al.
Publicado: (2022)

The cerebrospinal fluid immune cell landscape in animal models of multiple sclerosis
por: Wu, Gregory F.
Publicado: (2023)

Editorial: Animal models of multiple sclerosis: can they advance future therapies?
por: DeSilva, Tara Maria, et al.
Publicado: (2023)

Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
por: Packer, Davin, et al.
Publicado: (2023)

Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate
por: Aharoni, Rina, et al.
Publicado: (2019)

Epitope spreading in animal models: array of hope in rheumatoid arthritis and multiple sclerosis
por: Lundberg, Karin, et al.
Publicado: (2008)

Peripheral and Central Neuroinflammatory Changes and Pain Behaviors in an Animal Model of Multiple Sclerosis
por: Duffy, Samuel S., et al.
Publicado: (2016)

The Diversity of Encephalitogenic CD4+ T Cells in Multiple Sclerosis and Its Animal Models
por: Segal, Benjamin M.
Publicado: (2019)

Ectopic lymphoid follicles in progressive multiple sclerosis: From patients to animal models
por: Zhan, Jiangshan, et al.
Publicado: (2021)

Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis
por: Fiedler, Timon, et al.
Publicado: (2023)

From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment
por: Raghib, Muhammad Faraz, et al.
Publicado: (2023)

Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis
por: Shriver, Leah P., et al.
Publicado: (2011)

Inhibition of astrocytic DRD2 suppresses CNS inflammation in an animal model of multiple sclerosis
por: Lu, Shen-zhao, et al.
Publicado: (2022)

Altered Expression of Autophagy Biomarkers in Hippocampal Neurons in a Multiple Sclerosis Animal Model
por: Ceccariglia, Sabrina, et al.
Publicado: (2023)

Gene Expression Profile of Olfactory Transduction Signaling in an Animal Model of Human Multiple Sclerosis
por: Kim, Jeongtae, et al.
Publicado: (2019)

The formation of a glial scar does not prohibit remyelination in an animal model of multiple sclerosis
por: Haindl, Michaela Tanja, et al.
Publicado: (2018)

Oxygen treatment reduces neurological deficits and demyelination in two animal models of multiple sclerosis
por: Amatruda, Mario, et al.
Publicado: (2023)

Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis
por: Hooijmans, Carlijn R., et al.
Publicado: (2019)

Divergent complement system activation in two clinically distinct murine models of multiple sclerosis
por: Linzey, Michael, et al.
Publicado: (2022)

Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis
por: Zhornitsky, Simon, et al.
Publicado: (2015)

RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis
por: Manresa-Arraut, Alba, et al.
Publicado: (2018)

MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis
por: Talebi, Farideh, et al.
Publicado: (2017)

Potential Utility of Natural Products against Oxidative Stress in Animal Models of Multiple Sclerosis
por: Zha, Zheng, et al.
Publicado: (2022)

Obesity induced gut dysbiosis contributes to disease severity in an animal model of multiple sclerosis
por: Shahi, Shailesh K., et al.
Publicado: (2022)

The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data
por: Vakrakou, Aigli G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ihu0v75pm5oprlob2dq787br3u